<DOC>
	<DOCNO>NCT00856661</DOCNO>
	<brief_summary>The purpose study determine whether desmoteplase effective safe treatment patient acute ischaemic stroke give within 3 9 hour onset stroke symptom .</brief_summary>
	<brief_title>Efficacy Safety Study Desmoteplase Treat Acute Ischemic Stroke ( DIAS-4 )</brief_title>
	<detailed_description>Acute stroke major cause mortality long-term disability develop world . The currently approve thrombolytic intervention acute ischemic stroke , constitute majority stroke , alteplase ( recombinant tissue plasminogen activator ; rtPA ) . The use alteplase limit approve use within 3 hour symptom onset risk induce intracerebral haemorrhage ; consequently few 3 % acute stroke subject treat . The thrombolytic agent desmoteplase ( recombinant Desmodus Salivary Plasminogen Activator alpha-1 ; rDSPAalpha-1 ) produce recombinant biotechnology naturally occur counterpart saliva vampire bat Desmodus rotundus . Compared alteplase , desmoteplase favourable profile term high fibrin specificity non neurotoxicity . The study aim confirm efficacy safety desmoteplase thrombolytic therapy patient acute ischaemic stroke extend time window 3 9 hour onset stroke symptom .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Salivary plasminogen activator alpha 1 , Desmodus rotundus</mesh_term>
	<criteria>Diagnosis acute ischemic stroke Informed consent Age 18 85 year Treatment initiate within 3 9 hour onset stroke symptom NIHSS Score 4 24 Vessel occlusion highgrade stenosis MRI CTA proximal cerebral artery Prestroke mRS &gt; 1 Previous exposure desmoteplase Extensive early infarction MRI CT affect area Imaging evidence ICH SAH ; AV malformation ; cerebral aneurysm ; cerebral neoplasm Internal carotid artery occlusion side stroke lesion Treatment heparin past 48 hour prolong partial thromboplastin time Treatment oral anticoagulant prolong prothrombin time Treatment glycoprotein IIb IIIa inhibitor within past 72 hour . Use single agent oral platelet inhibitor permit Treatment thrombolytic agent within past 72 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Acute ischemic stroke</keyword>
	<keyword>Angiography</keyword>
	<keyword>Desmoteplase</keyword>
	<keyword>Thrombolytic</keyword>
</DOC>